Trials / Completed
CompletedNCT04166396
Non-pulmonary Contributors of Exercise Intolerance in Patients With Cystic Fibrosis
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Virginia Commonwealth University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this research study is to examine if the use of antioxidant supplements impacts exercise intolerance in people with CF.
Detailed description
Exercise intolerance is a critical problem for people with cystic fibrosis (CF) able to predict hospitalization independent of lung function. Recent studies have suggested that certain supplements may help improving exercise intolerance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Resveratrol | 500 mg resveratrol, BID |
| DRUG | NR | 500 mg NR BID |
| DIETARY_SUPPLEMENT | Placebo | Placebo |
Timeline
- Start date
- 2020-02-17
- Primary completion
- 2024-07-30
- Completion
- 2024-07-30
- First posted
- 2019-11-18
- Last updated
- 2025-07-03
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04166396. Inclusion in this directory is not an endorsement.